PDCD1 and neoplasm: Experiments conducted using Lewis lung carcinoma (LLC) cells demonstrate the activation of PI3K/Akt/mTOR pathway and its suppression by anti-PD-1 therapy, could result in activation of autophagy, suppression of angiogenesis and inhibition of tumor growth [81].